Abhishek Kumar
Uttaranchal Institute of Pharmaceutical Science, Uttaranchal University, Dehradun-248007, India

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Recent insights into nanostructured lipid carriers for novel drug delivery systems Deepika; Yogita Tyagi; Anjali Bhatt; Robin Raj; Abhishek Kumar
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.1932

Abstract

Background: Nanostructured lipid carriers (NLCs) are advanced lipid-based nanocarriers developed to overcome the limitations of conventional drug-delivery systems. Composed of a nanometric matrix of solid and liquid lipids, NLCs offer improved stability, safety, and drug-loading efficiency compared with other lipid, polymeric, or metallic nanoparticles. Their biocompatibility and non-toxicity make them attractive for pharmaceutical and biomedical applications. Methodology: This review systematically summarizes recent literature on NLC design, classification, structural characteristics, and preparation techniques. It discusses widely used formulation methods for lipid-based nanocarriers and strategies for surface modification to achieve targeted delivery and prolonged residence time. Results and Discussion: Nanostructured lipid carriers (NLCs) show high drug encapsulation efficiency, typically 70–95%, about 20–30% higher than conventional solid lipid nanoparticles (SLNs). Furthermore, NLCs enhance physicochemical stability, improve permeability, and increase the solubility of both hydrophilic and lipophilic drugs. Surface functionalization strategies enable controlled drug release and targeted delivery, thereby significantly improving therapeutic outcomes across multiple routes of administration. Because they can enhance bioavailability and protect encapsulated agents, NLCs are particularly well-suited for challenging delivery routes. Their versatility supports applications across a wide range of diseases, including infections, diabetes, cancer, neurodegenerative disorders, hypertension, and pain management. Conclusion: Overall, NLCs are a promising, versatile platform for safe and effective drug and gene delivery. Continued research and optimization may further expand their clinical potential across diverse therapeutic areas.